Clinical trials
Hepatitis B trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 27 |
| Gilead Sciences | 7 |
| Arrowhead Pharmaceuticals | 3 |
| Dynavax Technologies Corporation | 2 |
| Hannover Medical School | 2 |
| Vir Biotechnology, Inc. | 2 |
| Bristol-Myers Squibb | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| HepNet Study House, German Liverfoundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 55 |
| Hepatitis B, Chronic | 12 |
| Diphtheria | 7 |
| Hepatitis | 7 |
| Tetanus | 7 |
| Haemophilus Infections | 6 |
| Poliomyelitis | 6 |
| Hepatitis A | 3 |
| Whooping Cough | 3 |
| Hepatitis D | 2 |
Trials
Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.